Cargando…

Effective Information Provision About the Side Effects of Treatment for Malignant Lymphoma: Protocol of a Randomized Controlled Trial Using Video Vignettes

BACKGROUND: Informing patients with cancer about the possible implications of prospective treatment is a crucial yet challenging task. Unfortunately, patients’ recall of medical information is generally poor and their information needs are not met. Effective information giving entails that oncologis...

Descripción completa

Detalles Bibliográficos
Autores principales: Labrie, Nanon, van Dulmen, Sandra, Kersten, Marie José, de Haes, Hanneke JCM, Pieterse, Arwen H, van Weert, Julia CM, van Spronsen, Dick Johan, Smets, Ellen MA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521215/
https://www.ncbi.nlm.nih.gov/pubmed/31045506
http://dx.doi.org/10.2196/12453
_version_ 1783418905448939520
author Labrie, Nanon
van Dulmen, Sandra
Kersten, Marie José
de Haes, Hanneke JCM
Pieterse, Arwen H
van Weert, Julia CM
van Spronsen, Dick Johan
Smets, Ellen MA
author_facet Labrie, Nanon
van Dulmen, Sandra
Kersten, Marie José
de Haes, Hanneke JCM
Pieterse, Arwen H
van Weert, Julia CM
van Spronsen, Dick Johan
Smets, Ellen MA
author_sort Labrie, Nanon
collection PubMed
description BACKGROUND: Informing patients with cancer about the possible implications of prospective treatment is a crucial yet challenging task. Unfortunately, patients’ recall of medical information is generally poor and their information needs are not met. Effective information giving entails that oncologists help patients understand and recall the implications of their treatment, meanwhile fostering a trusting physician-patient relationship. Communication strategies that are often suggested to be effective are structuring and tailoring (cognition-oriented) but also are oncologists’ expressions of caring or empathy (affect-oriented). OBJECTIVE: The aim of this study is to provide evidence concerning the pathways linking physician communication to (improved) consultation outcomes for patients. More specifically, the aim is to determine the effects of information structuring and information tailoring, combined with physician caring, on information recall, satisfaction with information, and trust in the physician (primary objective) and on symptom distress (secondary objective). METHODS: A randomized controlled trial, systematically testing the effects of information structuring and information tailoring, each combined with caring, in 2 video-vignette experiments (2×2 and 2×2×2 design). Using an online survey platform, participants will be randomly allocated (blinded) to 1 of 12 conditions in which they are asked to view a video vignette (intervention) in which an oncologist discusses a treatment plan for malignant lymphoma with a patient. The independent variables of interest are systematically varied across conditions. The outcome measures are assessed in a survey, using validated instruments. Study participants are (former) patients with cancer and their relatives recruited via online panels and patient organizations. This protocol discusses the trial design, including the video-vignette design, intervention pretesting, and a pilot study. RESULTS: Data collection has now been completed, and preliminary analyses will be available in Spring 2019. A total of 470 participants completed the first part of the survey and were randomized to receive the intervention. CONCLUSIONS: The results of the proposed trial will provide evidence concerning the pathways linking physician information, giving skills to (improved) consultation outcomes for patients. TRIAL REGISTRATION: Netherlands Trial Register NTR6153; https://www.trialregister.nl/trial/6022 (Archived by Webcite at http://www.webcitation.org/76xVV9xC8). INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/12453
format Online
Article
Text
id pubmed-6521215
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-65212152019-06-07 Effective Information Provision About the Side Effects of Treatment for Malignant Lymphoma: Protocol of a Randomized Controlled Trial Using Video Vignettes Labrie, Nanon van Dulmen, Sandra Kersten, Marie José de Haes, Hanneke JCM Pieterse, Arwen H van Weert, Julia CM van Spronsen, Dick Johan Smets, Ellen MA JMIR Res Protoc Protocol BACKGROUND: Informing patients with cancer about the possible implications of prospective treatment is a crucial yet challenging task. Unfortunately, patients’ recall of medical information is generally poor and their information needs are not met. Effective information giving entails that oncologists help patients understand and recall the implications of their treatment, meanwhile fostering a trusting physician-patient relationship. Communication strategies that are often suggested to be effective are structuring and tailoring (cognition-oriented) but also are oncologists’ expressions of caring or empathy (affect-oriented). OBJECTIVE: The aim of this study is to provide evidence concerning the pathways linking physician communication to (improved) consultation outcomes for patients. More specifically, the aim is to determine the effects of information structuring and information tailoring, combined with physician caring, on information recall, satisfaction with information, and trust in the physician (primary objective) and on symptom distress (secondary objective). METHODS: A randomized controlled trial, systematically testing the effects of information structuring and information tailoring, each combined with caring, in 2 video-vignette experiments (2×2 and 2×2×2 design). Using an online survey platform, participants will be randomly allocated (blinded) to 1 of 12 conditions in which they are asked to view a video vignette (intervention) in which an oncologist discusses a treatment plan for malignant lymphoma with a patient. The independent variables of interest are systematically varied across conditions. The outcome measures are assessed in a survey, using validated instruments. Study participants are (former) patients with cancer and their relatives recruited via online panels and patient organizations. This protocol discusses the trial design, including the video-vignette design, intervention pretesting, and a pilot study. RESULTS: Data collection has now been completed, and preliminary analyses will be available in Spring 2019. A total of 470 participants completed the first part of the survey and were randomized to receive the intervention. CONCLUSIONS: The results of the proposed trial will provide evidence concerning the pathways linking physician information, giving skills to (improved) consultation outcomes for patients. TRIAL REGISTRATION: Netherlands Trial Register NTR6153; https://www.trialregister.nl/trial/6022 (Archived by Webcite at http://www.webcitation.org/76xVV9xC8). INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/12453 JMIR Publications 2019-05-02 /pmc/articles/PMC6521215/ /pubmed/31045506 http://dx.doi.org/10.2196/12453 Text en ©Nanon Labrie, Sandra van Dulmen, Marie José Kersten, Hanneke JCM de Haes, Arwen H Pieterse, Julia CM van Weert, Dick Johan van Spronsen, Ellen MA Smets, INSTRUCT Group. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 02.05.2019. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be included.
spellingShingle Protocol
Labrie, Nanon
van Dulmen, Sandra
Kersten, Marie José
de Haes, Hanneke JCM
Pieterse, Arwen H
van Weert, Julia CM
van Spronsen, Dick Johan
Smets, Ellen MA
Effective Information Provision About the Side Effects of Treatment for Malignant Lymphoma: Protocol of a Randomized Controlled Trial Using Video Vignettes
title Effective Information Provision About the Side Effects of Treatment for Malignant Lymphoma: Protocol of a Randomized Controlled Trial Using Video Vignettes
title_full Effective Information Provision About the Side Effects of Treatment for Malignant Lymphoma: Protocol of a Randomized Controlled Trial Using Video Vignettes
title_fullStr Effective Information Provision About the Side Effects of Treatment for Malignant Lymphoma: Protocol of a Randomized Controlled Trial Using Video Vignettes
title_full_unstemmed Effective Information Provision About the Side Effects of Treatment for Malignant Lymphoma: Protocol of a Randomized Controlled Trial Using Video Vignettes
title_short Effective Information Provision About the Side Effects of Treatment for Malignant Lymphoma: Protocol of a Randomized Controlled Trial Using Video Vignettes
title_sort effective information provision about the side effects of treatment for malignant lymphoma: protocol of a randomized controlled trial using video vignettes
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521215/
https://www.ncbi.nlm.nih.gov/pubmed/31045506
http://dx.doi.org/10.2196/12453
work_keys_str_mv AT labrienanon effectiveinformationprovisionaboutthesideeffectsoftreatmentformalignantlymphomaprotocolofarandomizedcontrolledtrialusingvideovignettes
AT vandulmensandra effectiveinformationprovisionaboutthesideeffectsoftreatmentformalignantlymphomaprotocolofarandomizedcontrolledtrialusingvideovignettes
AT kerstenmariejose effectiveinformationprovisionaboutthesideeffectsoftreatmentformalignantlymphomaprotocolofarandomizedcontrolledtrialusingvideovignettes
AT dehaeshannekejcm effectiveinformationprovisionaboutthesideeffectsoftreatmentformalignantlymphomaprotocolofarandomizedcontrolledtrialusingvideovignettes
AT pietersearwenh effectiveinformationprovisionaboutthesideeffectsoftreatmentformalignantlymphomaprotocolofarandomizedcontrolledtrialusingvideovignettes
AT vanweertjuliacm effectiveinformationprovisionaboutthesideeffectsoftreatmentformalignantlymphomaprotocolofarandomizedcontrolledtrialusingvideovignettes
AT vanspronsendickjohan effectiveinformationprovisionaboutthesideeffectsoftreatmentformalignantlymphomaprotocolofarandomizedcontrolledtrialusingvideovignettes
AT smetsellenma effectiveinformationprovisionaboutthesideeffectsoftreatmentformalignantlymphomaprotocolofarandomizedcontrolledtrialusingvideovignettes
AT effectiveinformationprovisionaboutthesideeffectsoftreatmentformalignantlymphomaprotocolofarandomizedcontrolledtrialusingvideovignettes